The Malaria Company
| Artecef® 50, im-injection |
NL RVG 24880 and SA 33/20.2.6./0305
|
| Artecef® 150, im-injection |
NL RVG 24881 and SA 33/20.2.6./0304 |
| A-CQ 100®, Chloroquine 100 mg |
NL RVG 106659 |
| A-PQ 30®, Primaquine 30 mg |
Reimbursed |
| A-QS 200, Quinine Sulphate-dihydrate 200 mg |
NL RVG 52455 |
| Malacef ® 60, pfi |
Orphan Drug Designation EU/3/07/430
ATU Nominative |
Artecef® 50 and 150 on the procurementlist of UN-agencies Quality and Safety Group of WHO, March 2006; LTA with UNICEF per November 2007, prolonged per November 2009.
ARTECEF BV is a subsidiary of ACE group of companies.